Alzheimer’s scares. Why? Because it is an illness that no one can cure
In Conversation
We are the only specialty pharma player exclusively dedicated to neuroscience and it is important that this shines through in our dealings with patients, practitioners and…
Diabetes has multiple pathologies: we count approximately 20,000 hospitalizations due to stroke, 8000 heart attacks 4,400 patients with chronic renal failure
Between 2007-2016, the number of biotech companies doubled in the Lyon region and there was a sharp increase in employment by 80 percent
Over the last decade, Nordic Pharma has gained renown for its niche and specialist products that respond to pressing unmet medical needs
Newcomers will enter through the less regulated part of the business and climb up the value chain to compete with us, in the same way that…
France is becoming the pro-business model in Europe. France has concrete and clear plans about how to move forward in a modern and dynamic way
Through encouraging collaboration, France will be more competitive on the international level and can also make a difference domestically
In France, we do not have a problem getting start-ups going. The challenge is much more about scaling-up these young, ambitious companies
I know first hand the importance of bringing together education, research and innovation
I do not consider Brexit to be a threat, but an opportunity to reinforce international collaboration and the importance of Europe
Lyon has become recognized nationally and internationally as possessing all the requisite qualities to host high value-added businesses without experiencing the downsides of much larger, sprawling…
